X

Trial Profile

Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 05 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Turoctocog alfa (Primary)
Indications Haemophilia A
Focus Therapeutic Use
Acronyms guardian TM 7
Sponsors Novo Nordisk

Most Recent Events

02 Jan 2019 Status changed from active, no longer recruiting to completed.
13 Mar 2018 New source identified and integrated (European Clinical Trials Database: EudraCT2013-004791-35)
22 Feb 2018 Planned primary completion date changed from 14 Dec 2018 to 11 Apr 2018.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com